Homeobox B2 is a potential prognostic biomarker of glioblastoma
Rev. Assoc. Med. Bras. (1992); 66 (6), 2020
SUMMARY OBJECTIVES HOXB2 is a new prognostic indicator for lung cancer. But it is unclear whether HOXB2 holds an effect in glioblastoma (GBM) progression. The purpose of this article was to probe the influences of HOXB2 on GBM pathogenesis. METHODS HOXB2 expression level and prognostic power in GBM p...